Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala, B Cai - BMC Infectious Diseases, 2022 - Springer
Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …

[HTML][HTML] Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis

EV Lemos, FP de La Hoz, TR Einarson… - Clinical Microbiology …, 2014 - Elsevier
Acinetobacter baumannii has emerged as a major cause of healthcare-associated
infections. Controversy exists as to whether antimicrobial resistance increases the risk of …

[HTML][HTML] Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia

EV Lemos, FP de la Hoz, N Alvis, TR Einarson… - Clinical Microbiology …, 2014 - Elsevier
Acinetobacter baumannii is a major cause of healthcare-associated infection, often affecting
critically ill patients. The purpose of the study was to examine the associations of …

Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii

I Rossi, S Royer, ML Ferreira, PA Campos… - American journal of …, 2019 - Elsevier
Background Carbapenem-resistant Acinetobacter baumannii (CR-Ab) has become a
worrying health care problem, mainly in developing countries, such as Brazil. The objective …

[HTML][HTML] Carbapenem-nonsusceptible Acinetobacter baumannii, 8 US metropolitan areas, 2012–2015

SN Bulens, HY Sarah, MS Walters… - Emerging infectious …, 2018 - ncbi.nlm.nih.gov
In healthcare settings, Acinetobacter spp. bacteria commonly demonstrate antimicrobial
resistance, making them a major treatment challenge. Nearly half of Acinetobacter …

Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions

M Wang, L Ge, L Chen, L Komarow… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAb) is 1 of the
most problematic antimicrobial-resistant bacteria. We sought to elucidate the international …

[HTML][HTML] Patient Demographics and Characteristics of Infection with Carbapenem-Resistant Acinetobacter baumannii in a Teaching Hospital from the United States

ND Vaze, CL Emery, RJ Hamilton, AD Brooks… - Advances in Infectious …, 2013 - scirp.org
A characterization of the clinical demographic features of patients with infection caused
Acinetobacter baumannii, and the antibiotyping of the isolates recovered from these patients …

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland

A Ramette, A Kronenberg… - BMC infectious …, 2018 - Springer
Background We describe the prevalence of invasive carbapenem-resistant Acinetobacter
spp. isolated from 2005 to 2016 in different regions of Switzerland. Methods Using the Swiss …

Carbapenem-resistant Acinetobacter baumannii in US hospitals: diversification of circulating lineages and antimicrobial resistance

A Iovleva, MM Mustapha, MP Griffith, L Komarow… - MBio, 2022 - Am Soc Microbiol
Carbapenem-resistant Acinetobacter baumannii (CR Ab) is a major cause of health care-
associated infections. CR Ab is typically multidrug resistant, and infection is difficult to treat …

Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five‐Year Case‐Control Study

S Yang, J Sun, X Wu, L Zhang - Canadian Journal of Infectious …, 2018 - Wiley Online Library
Purpose. This study was aimed to identify the determinants of in‐hospital mortality in
Acinetobacter baumannii (A. baumannii) bacteremia and to assess impact of carbapenem …